← Back to headlines
ImmunityBio Reaches New High on Anktiva Expansion Prospects
ImmunityBio (IBRX) stock soared to a new high, driven by optimism surrounding the future expansion of its drug Anktiva.
19 Feb, 11:08 — 19 Feb, 11:08
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Albanian MP Discusses Rising Prices, Stagnant Incomes, and EU Integration
10m ago
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
19m ago